rewirebio.iobenchmarks
Evidence claim

Relevance of ctdnajam-20261010-protocol-ccga1-training-cv-sens-98spec to "Which measured methylation workflow detects tumour-derived plasma DNA and, where separately supported, identifies tissue of origin?"

Use case
Select a plasma ctDNA methylation detection workflow
Assessed by
CCGA substudy 1 training set: cancer signal sensitivity at 98% specificity under 10-fold cross-validation
Relevance
Proxy evidence
Endpoint
Sensitivity (95% CI, TP/total) at 98% specificity under 10-fold cross-validation on 833 cancers and 560 non-cancers for the whole-genome methylation classifier and the five other classifiers that were analysed double-blinded in validation

Measures the use case's endpoint, all-stage cancer detection sensitivity at a declared specificity on plasma cfDNA, for a whole-genome bisulfite methylation classifier, alongside mutation, copy-number, fragment and clinical classifiers run on the same blood draws.

6 reviewed evaluations

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

21 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-c8bea25e5abb
Property and statementOriginal source and locationReview and provenance
Citation locations
1 values
  • source id
    ctdnajam-20261010-source-jamshidi2022
    locator
    Table 3, training columns; STAR Methods
Context-only references
Evaluation of cell-free DNA approaches for multi-cancer early detection

Original source ↗

ctdnajam-20261010-source-jamshidi2022: Table 3, training columns; STAR Methods

Version: Cancer Cell 40(12):1537-1549.e12, published 2022-12-12; publisher PDF (1-s2.0-S153561082200513X-main.pdf) as deposited by the Francis Crick Institute on figshare, 10.25418/crick.21731870.v1
Retrieved: 2026-10-10T06:05:17Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.citation_locators

Source artifact SHA-256: 5159294dd203d511dd437837a34555b276e14e0edf615bcb58bae5d9a1246d9a

Hash scope: pdftotext -layout text layer, parsed by extract/extract_ctdna_jamshidi.py

Inspected artifact

Comparison group
jamshidi2022-ccga1-detection
Context-only references
Evaluation of cell-free DNA approaches for multi-cancer early detection

Original source ↗

ctdnajam-20261010-source-jamshidi2022: Table 3, training columns; STAR Methods

Version: Cancer Cell 40(12):1537-1549.e12, published 2022-12-12; publisher PDF (1-s2.0-S153561082200513X-main.pdf) as deposited by the Francis Crick Institute on figshare, 10.25418/crick.21731870.v1
Retrieved: 2026-10-10T06:05:17Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.comparison_group

Source artifact SHA-256: 5159294dd203d511dd437837a34555b276e14e0edf615bcb58bae5d9a1246d9a

Hash scope: pdftotext -layout text layer, parsed by extract/extract_ctdna_jamshidi.py

Inspected artifact

Comparison title
CCGA substudy 1: cfDNA classifiers on the same participants at a post hoc 98% specificity
Context-only references
Evaluation of cell-free DNA approaches for multi-cancer early detection

Original source ↗

ctdnajam-20261010-source-jamshidi2022: Table 3, training columns; STAR Methods

Version: Cancer Cell 40(12):1537-1549.e12, published 2022-12-12; publisher PDF (1-s2.0-S153561082200513X-main.pdf) as deposited by the Francis Crick Institute on figshare, 10.25418/crick.21731870.v1
Retrieved: 2026-10-10T06:05:17Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.comparison_title

Source artifact SHA-256: 5159294dd203d511dd437837a34555b276e14e0edf615bcb58bae5d9a1246d9a

Hash scope: pdftotext -layout text layer, parsed by extract/extract_ctdna_jamshidi.py

Inspected artifact

Constraints
3 values
  • Inspect every linked evaluation's source locator and preserved limitations before citing a result.
  • Do not combine this mapping's evaluations with any other protocol's results; cohorts, assays and thresholds differ.
  • The 98% specificity threshold was set post hoc within each set and is not a locked screening threshold.
Context-only references
Evaluation of cell-free DNA approaches for multi-cancer early detection

Original source ↗

ctdnajam-20261010-source-jamshidi2022: Table 3, training columns; STAR Methods

Version: Cancer Cell 40(12):1537-1549.e12, published 2022-12-12; publisher PDF (1-s2.0-S153561082200513X-main.pdf) as deposited by the Francis Crick Institute on figshare, 10.25418/crick.21731870.v1
Retrieved: 2026-10-10T06:05:17Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.constraints

Source artifact SHA-256: 5159294dd203d511dd437837a34555b276e14e0edf615bcb58bae5d9a1246d9a

Hash scope: pdftotext -layout text layer, parsed by extract/extract_ctdna_jamshidi.py

Inspected artifact

Endpoint
Sensitivity (95% CI, TP/total) at 98% specificity under 10-fold cross-validation on 833 cancers and 560 non-cancers for the whole-genome methylation classifier and the five other classifiers that were analysed double-blinded in validation
Context-only references
Evaluation of cell-free DNA approaches for multi-cancer early detection

Original source ↗

ctdnajam-20261010-source-jamshidi2022: Table 3, training columns; STAR Methods

Version: Cancer Cell 40(12):1537-1549.e12, published 2022-12-12; publisher PDF (1-s2.0-S153561082200513X-main.pdf) as deposited by the Francis Crick Institute on figshare, 10.25418/crick.21731870.v1
Retrieved: 2026-10-10T06:05:17Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.endpoint

Source artifact SHA-256: 5159294dd203d511dd437837a34555b276e14e0edf615bcb58bae5d9a1246d9a

Hash scope: pdftotext -layout text layer, parsed by extract/extract_ctdna_jamshidi.py

Inspected artifact

Excluded evaluations
3 values
  • id
    ctdnajam-20261010-eval-training-fragment-endpoints
    reason
    Developed after validation blinding was lifted (STAR Methods), so its design may reflect the unblinded validation results. Excluded from this judgement at independent review 2026-10-10; it stays in the fragmentomics judgements with that limitation.
  • id
    ctdnajam-20261010-eval-training-fragment-lengths
    reason
    Developed after validation blinding was lifted (STAR Methods), so its design may reflect the unblinded validation results. Excluded from this judgement at independent review 2026-10-10; it stays in the fragmentomics judgements with that limitation.
  • id
    ctdnajam-20261010-eval-training-allelic-imbalance
    reason
    Developed after validation blinding was lifted (STAR Methods), so its design may reflect the unblinded validation results. Excluded from this judgement at independent review 2026-10-10; it stays in the fragmentomics judgements with that limitation.
Context-only references
Evaluation of cell-free DNA approaches for multi-cancer early detection

Original source ↗

ctdnajam-20261010-source-jamshidi2022: Table 3, training columns; STAR Methods

Version: Cancer Cell 40(12):1537-1549.e12, published 2022-12-12; publisher PDF (1-s2.0-S153561082200513X-main.pdf) as deposited by the Francis Crick Institute on figshare, 10.25418/crick.21731870.v1
Retrieved: 2026-10-10T06:05:17Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.excluded_evaluations

Source artifact SHA-256: 5159294dd203d511dd437837a34555b276e14e0edf615bcb58bae5d9a1246d9a

Hash scope: pdftotext -layout text layer, parsed by extract/extract_ctdna_jamshidi.py

Inspected artifact

Claimed field
links:assessed_by:ctdnajam-20261010-protocol-ccga1-training-cv-sens-98spec
Context-only references
Evaluation of cell-free DNA approaches for multi-cancer early detection

Original source ↗

ctdnajam-20261010-source-jamshidi2022: Table 3, training columns; STAR Methods

Version: Cancer Cell 40(12):1537-1549.e12, published 2022-12-12; publisher PDF (1-s2.0-S153561082200513X-main.pdf) as deposited by the Francis Crick Institute on figshare, 10.25418/crick.21731870.v1
Retrieved: 2026-10-10T06:05:17Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.field

Source artifact SHA-256: 5159294dd203d511dd437837a34555b276e14e0edf615bcb58bae5d9a1246d9a

Hash scope: pdftotext -layout text layer, parsed by extract/extract_ctdna_jamshidi.py

Inspected artifact

Headline metric
sensitivity-at-98-percent-specificity
Context-only references
Evaluation of cell-free DNA approaches for multi-cancer early detection

Original source ↗

ctdnajam-20261010-source-jamshidi2022: Table 3, training columns; STAR Methods

Version: Cancer Cell 40(12):1537-1549.e12, published 2022-12-12; publisher PDF (1-s2.0-S153561082200513X-main.pdf) as deposited by the Francis Crick Institute on figshare, 10.25418/crick.21731870.v1
Retrieved: 2026-10-10T06:05:17Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.headline_metric

Source artifact SHA-256: 5159294dd203d511dd437837a34555b276e14e0edf615bcb58bae5d9a1246d9a

Hash scope: pdftotext -layout text layer, parsed by extract/extract_ctdna_jamshidi.py

Inspected artifact

Limitations
8 values
  • Developer study: GRAIL designed the assays and classifiers, ran every arm, and reports the comparison.
  • The 98% specificity threshold was set post hoc within each set, including the validation set, so it is not a threshold locked before validation.
  • Case-control enrolment of clinically diagnosed cancers and matched non-cancer participants, not an intended-use screening population.
  • Prototype assays; the targeted methylation test developed afterwards is a different assay and is not scored here.
  • The fragment endpoints, fragment lengths, allelic imbalance and pan-feature classifiers were developed after validation blinding was lifted; the other classifiers were blinded.
  • Table 3 scores 833 training and 464 validation cancers against 854 and 485 analysable cancers in Table 1. STAR Methods restrict detection to solid cancers, and Table 1 lists 11 plasma cell neoplasms and 10 leukaemias in training and 8 and 13 in validation, which is 21 in each set; lymphomas stay in.
  • Specificity was 97.9% (548/560) in training and 97.8% (354/362) in validation for every cfDNA classifier, slightly below the 98% target.
  • Only the six classifiers analysed double-blinded in validation are shown; the three developed after unblinding are excluded.
Context-only references
Evaluation of cell-free DNA approaches for multi-cancer early detection

Original source ↗

ctdnajam-20261010-source-jamshidi2022: Table 3, training columns; STAR Methods

Version: Cancer Cell 40(12):1537-1549.e12, published 2022-12-12; publisher PDF (1-s2.0-S153561082200513X-main.pdf) as deposited by the Francis Crick Institute on figshare, 10.25418/crick.21731870.v1
Retrieved: 2026-10-10T06:05:17Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.limitations

Source artifact SHA-256: 5159294dd203d511dd437837a34555b276e14e0edf615bcb58bae5d9a1246d9a

Hash scope: pdftotext -layout text layer, parsed by extract/extract_ctdna_jamshidi.py

Inspected artifact

Pinned records
15 values
  • record id
    ctdnajam-20261010-eval-training-clinical-data
    fields
    • status
    • links
    • attributes.origin
    • attributes.comparison
    sha256
    1d52b51d39fa7581e10f3a7fc9011a7d0d58bbe4a0d40d22e728eeccb33136fb
  • record id
    ctdnajam-20261010-eval-training-scna
    fields
    • status
    • links
    • attributes.origin
    • attributes.comparison
    sha256
    308b3a9f74982fbe8704819025d5434558cf07ab23b8b80e2c06d7ea9e36b864
  • record id
    ctdnajam-20261010-eval-training-scna-wbc
    fields
    • status
    • links
    • attributes.origin
    • attributes.comparison
    sha256
    d60a82250add685a70cec0035e890ff8cca597a2f18ee755711cda02d740da51
  • record id
    ctdnajam-20261010-eval-training-snv
    fields
    • status
    • links
    • attributes.origin
    • attributes.comparison
    sha256
    b192bf6cb8b40bfd6a9bac2d7e8e46dc3b8260dc3ba58443d7f4d4db21c5c9cc
  • record id
    ctdnajam-20261010-eval-training-snv-wbc
    fields
    • status
    • links
    • attributes.origin
    • attributes.comparison
    sha256
    9eeb50a8399c1e7382a39110181b54c03a30f28899434225f6090baf61fd98ad
  • record id
    ctdnajam-20261010-eval-training-wg-methylation
    fields
    • status
    • links
    • attributes.origin
    • attributes.comparison
    sha256
    ee219db71a2d985de4b230b91d409083aa64e21e996808f8df1bf3297e6562a9
  • record id
    ctdnajam-20261010-protocol-ccga1-training-cv-sens-98spec
    fields
    • status
    • name
    • description
    • facets
    • source_ids
    • links
    • attributes
    sha256
    989df2f01c0e0680982046687453cf8e01eaff06fdd2cef30b77956a4c047935
  • record id
    ctdnajam-20261010-result-training-clinical-data-sensitivity
    fields
    • status
    • attributes.metric
    • attributes.metric_qualifier
    • attributes.printed_value
    • attributes.numeric_value
    sha256
    9aa5ea94d9bc7d5a2d13ca1fb78c40c6eb3ec8d957f7c10d44ef389c0dc3b25f
  • record id
    ctdnajam-20261010-result-training-scna-sensitivity
    fields
    • status
    • attributes.metric
    • attributes.metric_qualifier
    • attributes.printed_value
    • attributes.numeric_value
    sha256
    55800b64e75e349c9574302a38d6f4e067437e0161e3e02c76d784e3bfc486a0
  • record id
    ctdnajam-20261010-result-training-scna-wbc-sensitivity
    fields
    • status
    • attributes.metric
    • attributes.metric_qualifier
    • attributes.printed_value
    • attributes.numeric_value
    sha256
    473993745009b5df1d857d423f4dcb9e5c66f3f43e99ce6fb4397d3c6a81bebd
  • record id
    ctdnajam-20261010-result-training-snv-sensitivity
    fields
    • status
    • attributes.metric
    • attributes.metric_qualifier
    • attributes.printed_value
    • attributes.numeric_value
    sha256
    9c699789969b9519eb9134425fbb111acd7b94729d7dd9e2f08ab2d306436716
  • record id
    ctdnajam-20261010-result-training-snv-wbc-sensitivity
    fields
    • status
    • attributes.metric
    • attributes.metric_qualifier
    • attributes.printed_value
    • attributes.numeric_value
    sha256
    311545249c9bd2489f49e6fb53bf049a45a90e4987054e8f1088bb2cf8f7151e
  • record id
    ctdnajam-20261010-result-training-wg-methylation-sensitivity
    fields
    • status
    • attributes.metric
    • attributes.metric_qualifier
    • attributes.printed_value
    • attributes.numeric_value
    sha256
    3d870e6f22ac02c7ff9605e5bd212bbd87657fc2e225ec789da75e4b2ddd3f40
  • record id
    ctdnajam-20261010-source-jamshidi2022
    fields
    • status
    • attributes.artifact_sha256
    sha256
    49c49ed0c10c6121644dee3068618d9f5a06bbc63f5979bc8417acd9c1c0e56e
  • record id
    use-case-plasma-ctdna-methylation
    fields
    • status
    • name
    • description
    • facets
    • attributes.question
    • attributes.decision
    • attributes.inputs
    • attributes.output
    • attributes.exclusions
    • attributes.setting
    • attributes.clinical_scope
    • attributes.intended_users
    sha256
    4d9542463e1400d5d9701c7f52859a23e4c78804cbda1477663445f945e22429
Context-only references
Evaluation of cell-free DNA approaches for multi-cancer early detection

Original source ↗

ctdnajam-20261010-source-jamshidi2022: Table 3, training columns; STAR Methods

Version: Cancer Cell 40(12):1537-1549.e12, published 2022-12-12; publisher PDF (1-s2.0-S153561082200513X-main.pdf) as deposited by the Francis Crick Institute on figshare, 10.25418/crick.21731870.v1
Retrieved: 2026-10-10T06:05:17Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.pins

Source artifact SHA-256: 5159294dd203d511dd437837a34555b276e14e0edf615bcb58bae5d9a1246d9a

Hash scope: pdftotext -layout text layer, parsed by extract/extract_ctdna_jamshidi.py

Inspected artifact

How to read the evidence

Sources and history

Release 2026-11-21-c8bea25e5abb · Record review: source checked

1 source record and release historyDownload this release (gzip)
Technical metadata and extraction receipts

Stable ID: use-case-mapping-ctdna-jamshidi-20261010-meth-training-cv

field
links:assessed_by:ctdnajam-20261010-protocol-ccga1-training-cv-sens-98spec
value
ctdnajam-20261010-protocol-ccga1-training-cv-sens-98spec
relevance
proxy
endpoint
Sensitivity (95% CI, TP/total) at 98% specificity under 10-fold cross-validation on 833 cancers and 560 non-cancers for the whole-genome methylation classifier and the five other classifiers that were analysed double-blinded in validation
rationale
Cross-validated sensitivity at a post hoc 98% specificity within the training set used to design the classifiers. Proxy, because the same study's independent validation set gives the direct estimate for the same locked classifiers; the training values show how much sensitivity fell between training and validation (WG methylation 39% to 34%). Developer-run and case-control. The CCGA samples are not public and do not overlap the cohorts of this use case's other judgements.
constraints
Inspect every linked evaluation's source locator and preserved limitations before citing a result.; Do not combine this mapping's evaluations with any other protocol's results; cohorts, assays and thresholds differ.; The 98% specificity threshold was set post hoc within each set and is not a locked screening threshold.
limitations
Developer study: GRAIL designed the assays and classifiers, ran every arm, and reports the comparison.; The 98% specificity threshold was set post hoc within each set, including the validation set, so it is not a threshold locked before validation.; Case-control enrolment of clinically diagnosed cancers and matched non-cancer participants, not an intended-use screening population.; Prototype assays; the targeted methylation test developed afterwards is a different assay and is not scored here.; The fragment endpoints, fragment lengths, allelic imbalance and pan-feature classifiers were developed after validation blinding was lifted; the other classifiers were blinded.; Table 3 scores 833 training and 464 validation cancers against 854 and 485 analysable cancers in Table 1. STAR Methods restrict detection to solid cancers, and Table 1 lists 11 plasma cell neoplasms and 10 leukaemias in training and 8 and 13 in validation, which is 21 in each set; lymphomas stay in.; Specificity was 97.9% (548/560) in training and 97.8% (354/362) in validation for every cfDNA classifier, slightly below the 98% target.; Only the six classifiers analysed double-blinded in validation are shown; the three developed after unblinding are excluded.
citation locators
source id: ctdnajam-20261010-source-jamshidi2022; locator: Table 3, training columns; STAR Methods
source locator
ctdnajam-20261010-source-jamshidi2022: Table 3, training columns; STAR Methods
revision
1
reason
Add the CCGA substudy 1 same-sample comparison of cfDNA classifiers (Jamshidi et al. 2022), retrieved 2026-10-10.
comparison group
jamshidi2022-ccga1-detection
comparison title
CCGA substudy 1: cfDNA classifiers on the same participants at a post hoc 98% specificity
headline metric
sensitivity-at-98-percent-specificity
stratum label
Training set, 10-fold cross-validation
stratum order
1
excluded evaluations
id: ctdnajam-20261010-eval-training-fragment-endpoints; reason: Developed after validation blinding was lifted (STAR Methods), so its design may reflect the unblinded validation results. Excluded from this judgement at independent review 2026-10-10; it stays in the fragmentomics judgements with that limitation.; id: ctdnajam-20261010-eval-training-fragment-lengths; reason: Developed after validation blinding was lifted (STAR Methods), so its design may reflect the unblinded validation results. Excluded from this judgement at independent review 2026-10-10; it stays in the fragmentomics judgements with that limitation.; id: ctdnajam-20261010-eval-training-allelic-imbalance; reason: Developed after validation blinding was lifted (STAR Methods), so its design may reflect the unblinded validation results. Excluded from this judgement at independent review 2026-10-10; it stays in the fragmentomics judgements with that limitation.
reviewed evaluations
ctdnajam-20261010-eval-training-clinical-data; ctdnajam-20261010-eval-training-scna; ctdnajam-20261010-eval-training-scna-wbc; ctdnajam-20261010-eval-training-snv; ctdnajam-20261010-eval-training-snv-wbc; ctdnajam-20261010-eval-training-wg-methylation
review
method: automated-source-review; reviewer: claude; reviewer note: Separate Claude review agent, independent of the extractor; no human review claimed; reviewed at: 2026-10-10T09:00:00Z; note: Independent review of endpoint fit, relevance grade, limitations, exclusions and grouping against the use case and the article; every value of the listed evaluations was checked against Table 3 or the Results text, with percentages and Clopper-Pearson intervals recomputed. Developer study; no execution, reproduction, human scientific review or clinical validation.
pins
record id: ctdnajam-20261010-eval-training-clinical-data; fields: status; links; attributes.origin; attributes.comparison; sha256: 1d52b51d39fa7581e10f3a7fc9011a7d0d58bbe4a0d40d22e728eeccb33136fb; record id: ctdnajam-20261010-eval-training-scna; fields: status; links; attributes.origin; attributes.comparison; sha256: 308b3a9f74982fbe8704819025d5434558cf07ab23b8b80e2c06d7ea9e36b864; record id: ctdnajam-20261010-eval-training-scna-wbc; fields: status; links; attributes.origin; attributes.comparison; sha256: d60a82250add685a70cec0035e890ff8cca597a2f18ee755711cda02d740da51; record id: ctdnajam-20261010-eval-training-snv; fields: status; links; attributes.origin; attributes.comparison; sha256: b192bf6cb8b40bfd6a9bac2d7e8e46dc3b8260dc3ba58443d7f4d4db21c5c9cc; record id: ctdnajam-20261010-eval-training-snv-wbc; fields: status; links; attributes.origin; attributes.comparison; sha256: 9eeb50a8399c1e7382a39110181b54c03a30f28899434225f6090baf61fd98ad; record id: ctdnajam-20261010-eval-training-wg-methylation; fields: status; links; attributes.origin; attributes.comparison; sha256: ee219db71a2d985de4b230b91d409083aa64e21e996808f8df1bf3297e6562a9; record id: ctdnajam-20261010-protocol-ccga1-training-cv-sens-98spec; fields: status; name; description; facets; source_ids; links; attributes; sha256: 989df2f01c0e0680982046687453cf8e01eaff06fdd2cef30b77956a4c047935; record id: ctdnajam-20261010-result-training-clinical-data-sensitivity; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 9aa5ea94d9bc7d5a2d13ca1fb78c40c6eb3ec8d957f7c10d44ef389c0dc3b25f; record id: ctdnajam-20261010-result-training-scna-sensitivity; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 55800b64e75e349c9574302a38d6f4e067437e0161e3e02c76d784e3bfc486a0; record id: ctdnajam-20261010-result-training-scna-wbc-sensitivity; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 473993745009b5df1d857d423f4dcb9e5c66f3f43e99ce6fb4397d3c6a81bebd; record id: ctdnajam-20261010-result-training-snv-sensitivity; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 9c699789969b9519eb9134425fbb111acd7b94729d7dd9e2f08ab2d306436716; record id: ctdnajam-20261010-result-training-snv-wbc-sensitivity; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 311545249c9bd2489f49e6fb53bf049a45a90e4987054e8f1088bb2cf8f7151e; record id: ctdnajam-20261010-result-training-wg-methylation-sensitivity; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 3d870e6f22ac02c7ff9605e5bd212bbd87657fc2e225ec789da75e4b2ddd3f40; record id: ctdnajam-20261010-source-jamshidi2022; fields: status; attributes.artifact_sha256; sha256: 49c49ed0c10c6121644dee3068618d9f5a06bbc63f5979bc8417acd9c1c0e56e; record id: use-case-plasma-ctdna-methylation; fields: status; name; description; facets; attributes.question; attributes.decision; attributes.inputs; attributes.output; attributes.exclusions; attributes.setting; attributes.clinical_scope; attributes.intended_users; sha256: 4d9542463e1400d5d9701c7f52859a23e4c78804cbda1477663445f945e22429
Related records

Suggest a correction